Free Trial
→ $2 Trillion Disappears Because of Fed's Secretive New Move (From Stansberry Research) (Ad) Buy OTLK Stock  Free OTLK Stock Alerts

Outlook Therapeutics (OTLK) SEC Filings & 10K Form

Outlook Therapeutics logo
$1.54 -0.02 (-0.97%)
As of 02:38 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Outlook Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/10/2025
4:28 PM		Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Form SCHEDULE 13G/A
03/30/2025
11:15 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
03/28/2025
3:44 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 424B3
03/12/2025
8:11 PM		GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Form SCHEDULE 13D/A
03/12/2025
7:56 PM		GMS Ventures & Investments (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Ghiath M. (Reporting)
Form 4/A
03/09/2025
11:15 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
02/28/2025
3:37 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/28/2025
7:17 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:38 PM		Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
7:14 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
3:16 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form DEF 14A
02/10/2025
3:19 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form ARS
02/06/2025
3:40 PM		Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:46 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form PRE 14A
01/31/2025
3:39 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
4:04 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/23/2025
4:00 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 10-K/A
01/22/2025
3:17 PM		GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Form SCHEDULE 13D/A
01/16/2025
4:16 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
3:30 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/27/2024
7:14 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
3:11 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2024
6:27 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
11:26 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:55 PM		GREAT POINT PARTNERS LLC (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Form SC 13G/A
10/03/2024
8:22 PM		Gangolli Julian S (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
THURMAN RANDY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		HILZINGER KURT J (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Auffarth Gerd (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM		Haller Julia A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:53 PM		KENYON LAWRENCE A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:48 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
7:41 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
6:25 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form DEF 14A
05/15/2024
4:19 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
11:15 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
05/01/2024
5:02 AM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:18 PM		Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
What President Trump’s Executive Order 14154 means for your money (Ad)

Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard.

But because of the massive changes impacting U.S. stocks, Tilson has agreed to publish his latest fi
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:OTLK) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners
Feds Just Admitted It—They Can Take Your Cash
Here’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...
Priority Gold | Sponsored
Trump Makes Major Crypto Announcement
Trump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...
Crypto 101 Media | Sponsored
James Altucher: Do not invest in AI unless…
I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...
Paradigm Press | Sponsored
The Exact July Date the AI Correction Will End?
AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...
Brownstone Research | Sponsored
This Is The Moment You Betray Trump (Or Prove Them Wrong)
They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...
Colonial Metals | Sponsored
Virtually Limitless Energy?
A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...
Stansberry Research | Sponsored
Musk’s real agenda in D.C.
In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...
Porter & Company | Sponsored